Voltaren shortage — US supply status & alternatives

Voltaren

—

🇦🇺 AUST R 11072 · Novartis Pharmaceuticals Australia Pty Ltd

In supply · Australia

In supply · 🇦🇺 Australia · short in🇺🇸 US🇪🇸 ES

In supply in Australia

Reading today’s signals…

✓ Can I substitute?

In supply

no shortage substitution needed

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Active ingredient (INN)	Voltaren
Therapeutic category	Auto-created by Agencia Española de Medicamentos — Problemas de Suministro scraper
Controlled substance	No

Registrations on file	29

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

How long have past shortages lasted? from 3 resolved events

◷

0–2 months

Historical pattern from resolved shortage records — not a prediction of this event.

Shortage status by regulator official notices

🇺🇸

United States

FDA MedWatch · 1mo ago

High

🇪🇸

Spain

AEMPS · 2d ago

Medium

Recalls official enforcement reports

🇺🇸

Voltaren

Physicians Total Care, Inc. · Mar 2013

Class IIIdetails ↗

Verified timeline regulator events

🇪🇸 7 June 2026

Shortage resolved

🇪🇸 3 May 2026

Shortage resolved

🇪🇸 21 Dec 2025

medium reported

🇪🇸 24 Sept 2025

medium reported

🇪🇸 30 July 2025

Shortage resolved

🇺🇸 23 June 2022

high reported

Sources official regulators

🇪🇸

AEMPS

verified 2d ago

verify ↗

🇺🇸

FDA MedWatch

verified 1mo ago

verify ↗

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders29 registrations · 6 MA holders

Product	Strength	Form	Market	MA holder	Status
Voltaren	10mg/g	gel	🇺🇸 US	Haleon US Holdings LLC	Active
Voltaren	—	kit	🇺🇸 US	Haleon US Holdings LLC	Active
VOLTAREN diclofenac sodium	25 mg	—	🇦🇺 AU	Novartis Pharmaceuticals Australia Pty Ltd	Active
VOLTAREN 50 diclofenac sodium 50mg tablet bottle	50mg	—	🇦🇺 AU	Novartis Pharmaceuticals Australia Pty Ltd	Active
VOLTAREN diclofenac sodium	100mg	—	🇦🇺 AU	Novartis Pharmaceuticals Australia Pty Ltd	Active
VOLTAREN RAPID EXTRA STRENGTH diclofenac potassium	25 mg	—	🇦🇺 AU	GlaxoSmithKline Consumer Healthcare Australia Pty Ltd	Active
Voltaren Rapid	50mg	—	🇦🇺 AU	Novartis Pharmaceuticals Australia Pty Ltd	Active
VOLTAREN PAIN RELIEF GEL diclofenac diethylamine	11.6mg	—	🇦🇺 AU	GlaxoSmithKline Consumer Healthcare Australia Pty Ltd	Active
VOLTAREN 50 diclofenac sodium 50mg tablet blister pack	50mg	—	🇦🇺 AU	Novartis Pharmaceuticals Australia Pty Ltd	Active
VOLTAREN diclofenac sodium	12.5mg	—	🇦🇺 AU	Novartis Pharmaceuticals Australia Pty Ltd	Active
VOLTAREN diclofenac sodium	25mg	—	🇦🇺 AU	Novartis Pharmaceuticals Australia Pty Ltd	Active
VOLTAREN diclofenac sodium	50mg	—	🇦🇺 AU	Novartis Pharmaceuticals Australia Pty Ltd	Active
VOLTAREN OPHTHA diclofenac sodium	1mg	—	🇦🇺 AU	Novartis Pharmaceuticals Australia Pty Ltd	Active
VOLTAREN 25 diclofenac sodium 25mg tablet blister pack	25mg	—	🇦🇺 AU	Novartis Pharmaceuticals Australia Pty Ltd	Active
VOLTAREN RAPID diclofenac potassium	12.5 mg	—	🇦🇺 AU	GlaxoSmithKline Consumer Healthcare Australia Pty Ltd	Active

+14 more registrations on file

Mederti Drug Report

Generated 3 July 2026 · Australia market · 2 regulatory sources

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.